ENTITY

Geron Corp (GERN US)

3
Analysis
Health CareUnited States
Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
more
Company Event08 Mar 2025 05:00 • Upcoming
Add To Calendar
Company Event07 Nov 2024 21:00 • Latest
Company Event08 Aug 2024 20:00
Company Event02 May 2024 20:00
x